Skip to main content
Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.486
-0.064 (-11.64%)
At close: Mar 9, 2026, 4:00 PM EDT
0.519
+0.033 (6.87%)
After-hours: Mar 9, 2026, 7:36 PM EDT

Harvard Bioscience Revenue

Harvard Bioscience had revenue of $20.59M in the quarter ending September 30, 2025, a decrease of -6.28%. This brings the company's revenue in the last twelve months to $87.37M, down -10.60% year-over-year. In the year 2024, Harvard Bioscience had annual revenue of $94.14M, down -16.14%.

Revenue (ttm)
$87.37M
Revenue Growth
-10.60%
P/S Ratio
0.25
Revenue / Employee
$246,115
Employees
355
Market Cap
21.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202494.14M-18.12M-16.14%
Dec 31, 2023112.25M-1.09M-0.96%
Dec 31, 2022113.34M-5.57M-4.68%
Dec 31, 2021118.90M16.80M16.46%
Dec 31, 2020102.10M-14.08M-12.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Retractable Technologies 37.90M
Bionano Genomics 28.72M
Precision Optics Corporation 24.42M
Jin Medical International 20.69M
Nephros 17.93M
Ekso Bionics Holdings 12.80M
NEXGEL 11.67M
Milestone Scientific 8.93M
Revenue Rankings

HBIO News

More News